<DOC>
	<DOCNO>NCT02169934</DOCNO>
	<brief_summary>The purpose study determine rout excretion TRV130 's metabolite , determine characterize , structurally , metabolites present plasma , urine , feces healthy male subject .</brief_summary>
	<brief_title>A Study Investigate Metabolism Excretion 14C-TRV130 Healthy Male Subjects</brief_title>
	<detailed_description>This study open-label , non-randomized , metabolism excretion study single 2 mg IV dose [ 14C ] TRV130 ( approximately 100 µCi ) administer 10 mL manual IV push 2 minute fast state .</detailed_description>
	<criteria>Key Males , 18 64 year age , inclusive With body weight ≥ 50 kg body mass index ( BMI ) 18 32 kg/m2 , inclusive In good health , determine clinically significant finding medical history , 12lead ECG , vital sign Negative test select drug abuse Screening Checkin Able comprehend willing sign Informed Consent Form ( ICF ) prior study procedure A typical minimum 1 2 bowel movement per day Key History sensitivity study medication component thereof history medication allergy , opinion Investigator , contraindicate participation Participation investigational study drug trial receipt investigational study drug occur within 28 day prior Checkin Participation radiolabeled investigational study drug trial within 12 month prior Checkin Exposure significant radiation ( eg , serial xray compute tomography scan , barium meal , current employment job require radiation exposure monitoring ) within 12 month prior Checkin Has current malignancy , current systemic chemotherapy , cancer diagnosis within 5 year prior Screening ( exclude squamous basal cell carcinoma skin clinically stable fully excise curative procedure ) ; Use tobacco nicotinecontaining product within 6 month prior Screening</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>